Headquarters:
Lexington, MA
Description:
Concert Pharmaceuticals is a biotechnology company utilizing deuterium to develop novel medical candidates.
Founders:
Richard Aldrich, Roger Tung
Categories:
Health Care, Biotechnology
Website:
http://www.concertpharma.com

Company Details

Update

Founded in April 2006, Concert Pharmaceuticals is a clinical stage biotechnology company dedicated to creating new medicines through a novel scientific approach utilizing the naturally-occurring element deuterium.

Concert applies its innovative precision deuterium chemistry platform to modify specific properties of validated drug molecules, yielding a rich pipeline of new chemical entities (NCEs). Concert leverages decades of pharmaceutical experience to create novel drug candidates with potential for best-in-class efficacy and safety, while greatly reducing R&D risk, time and expense.

Current Team (6)

Update

Past Team (4)

Update

Board Members and Advisors (7)

Update

Investors (13)

Update

Offices/Locations (1)

Update
  • Corporate Headquarters

    99 Hayden Avenue

    Suite 500

    Lexington, MA 02421

    USA

Images (1)

Update
  • 42e26bf316a6c11d64c446de45137c35